tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Amplia Therapeutics Advances US Clinical Trial Plans with FDA Approval
Company AnnouncementsAmplia Therapeutics Advances US Clinical Trial Plans with FDA Approval
23h ago
Amplia Therapeutics Adjusts Option Exercise Prices Post Capital Raising
PremiumCompany Announcements
Amplia Therapeutics Adjusts Option Exercise Prices Post Capital Raising
19d ago
Amplia Therapeutics Completes Early Recruitment for Promising Pancreatic Cancer Trial
PremiumCompany Announcements
Amplia Therapeutics Completes Early Recruitment for Promising Pancreatic Cancer Trial
1M ago
Amplia Therapeutics Advances Cancer Treatment with Promising Trial Results and Strategic Collaborations
PremiumCompany Announcements
Amplia Therapeutics Advances Cancer Treatment with Promising Trial Results and Strategic Collaborations
1M ago
Amplia Therapeutics Unveils Promising Data for Narmafotinib at Keystone Meeting
PremiumCompany Announcements
Amplia Therapeutics Unveils Promising Data for Narmafotinib at Keystone Meeting
1M ago
Amplia Therapeutics Secures $13 Million in Capital Raise
PremiumCompany AnnouncementsAmplia Therapeutics Secures $13 Million in Capital Raise
2M ago
Amplia Therapeutics Announces Director’s Increased Shareholding
Premium
Company Announcements
Amplia Therapeutics Announces Director’s Increased Shareholding
2M ago
Amplia Therapeutics Announces Director’s Share Acquisition
Premium
Company Announcements
Amplia Therapeutics Announces Director’s Share Acquisition
2M ago
Amplia Therapeutics Announces Change in Director’s Interest
PremiumCompany Announcements
Amplia Therapeutics Announces Change in Director’s Interest
2M ago
Amplia Therapeutics Director Increases Stake, Boosting Investor Interest
PremiumCompany Announcements
Amplia Therapeutics Director Increases Stake, Boosting Investor Interest
2M ago
Amplia Therapeutics Lists New Securities on ASX
PremiumCompany Announcements
Amplia Therapeutics Lists New Securities on ASX
2M ago
Amplia Therapeutics Issues New Equity Options
PremiumCompany Announcements
Amplia Therapeutics Issues New Equity Options
2M ago
Amplia Therapeutics Shows Promising Data in Cancer Trial
PremiumCompany AnnouncementsAmplia Therapeutics Shows Promising Data in Cancer Trial
3M ago
Acorn Capital Increases Stake in Amplia Therapeutics
Premium
Company Announcements
Acorn Capital Increases Stake in Amplia Therapeutics
3M ago
Amplia Therapeutics Reports Increased Losses Amid Revenue Decline
Premium
Company Announcements
Amplia Therapeutics Reports Increased Losses Amid Revenue Decline
3M ago
Amplia Therapeutics Completes Successful Fundraising Effort
PremiumCompany Announcements
Amplia Therapeutics Completes Successful Fundraising Effort
3M ago
Amplia Therapeutics Sets EGM for Shareholder Approvals
PremiumCompany Announcements
Amplia Therapeutics Sets EGM for Shareholder Approvals
4M ago
Amplia Therapeutics Partners with Next&Bio for Cancer Research
PremiumCompany Announcements
Amplia Therapeutics Partners with Next&Bio for Cancer Research
4M ago
Amplia Therapeutics Shareholding Update by Platinum Asset
PremiumCompany Announcements
Amplia Therapeutics Shareholding Update by Platinum Asset
4M ago
Amplia Therapeutics Completes $13M Share Allotment
PremiumCompany AnnouncementsAmplia Therapeutics Completes $13M Share Allotment
4M ago
Amplia Therapeutics Lists New Shares on ASX
Premium
Company Announcements
Amplia Therapeutics Lists New Shares on ASX
4M ago
Amplia Therapeutics to Issue New Securities on ASX
Premium
Company Announcements
Amplia Therapeutics to Issue New Securities on ASX
4M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >